BIONXT SOLUTIONS INC.
BXT.XETRA | Activities of holding companies
BIONXT SOLUTIONS INC. is a German company focused on the life sciences sector. It operates as an investment entity, acquiring and managing holdings in companies involved in the research, development, and commercialization of innovative technologies and products within the biotechnology, pharmaceutic...Show More
Better Health for All
20
BioNxt Solutions Inc. is focused on developing next-generation drug delivery systems for neurodegenerative, autoimmune diseases, and cancer. Its principal goods and services, currently in development, are designed to deliver transformative health benefits. For instance, its chemotherapy drug delivery platform aims to increase therapeutic effect 10-fold while minimizing systemic exposure and reducing harmful side effects in preclinical trials.
1
Other products, such as ODF Cladribine for Multiple Sclerosis and Myasthenia Gravis, aim to improve treatment outcomes through high efficacy, rapid absorption, improved patient compliance, lower doses, and reduced side effects. The company's business model is entirely devoted to health improvement, with no revenue from products with established negative health outcomes. The company's products do not have addiction potential, and it is not a food company.
2
Fair Money & Economic Opportunity
0
BioNxt Solutions Inc. operates in the life sciences sector, focusing on the research, development, and commercialization of drug delivery systems for neurodegenerative and autoimmune diseases. The company's activities, as detailed in the provided articles, are centered on pharmaceutical products and patenting related technologies. There is no evidence that BioNxt Solutions Inc. offers lending, deposit, or any other financial services to consumers or businesses. Consequently, all Key Performance Indicators related to 'Fair Money & Economic Opportunity' are not applicable to the company's core business model.
Fair Pay & Worker Respect
0
The company operates as an investment entity, which means the CEO to median employee pay ratio is not applicable according to the rubric. No other specific, concrete data points were provided across the articles for any other Fair Pay & Worker Respect KPIs.
Fair Trade & Ethical Sourcing
0
No quantitative evidence was found in the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing. The articles discuss general financial information
1
, the importance of supply chain sustainability
2
, and a Code of Conduct from 'Bionorica' (which is not explicitly stated to be BIONXT SOLUTIONS INC or its subsidiary)
3
, but none provide specific data points such as percentages of certified spend
4
, audit frequencies
5
, incident numbers
6
, traceability coverage
7
, remediation times
8
, ethical clause coverage
9
, materials risk
10
, or supplier diversity metrics for BXT.XETRA
11
.
Honest & Fair Business
40
The annual consolidated financial statements for the year ended December 31, 2024, were audited.
1
However, the interim financial statements for the six months ended June 30, 2025, and 2024, were not reviewed by an auditor.
2
The company was subject to a temporary Management Cease Trade Order (MCTO) issued by the British Columbia Securities Commission on May 1, 2025, due to a delay in filing its annual audited financial statements for 2024.
3
This MCTO was revoked on June 27, 2025, after the company filed the required documents on June 26, 2025.
4
Kind to Animals
-70
BIONXT SOLUTIONS INC. is actively conducting and planning animal studies for its drug development, BNT23001.
1
Small-mass animal trials, using animals weighing less than 20 kg, have been completed.
2
A large-mass animal study, using animals weighing more than 40 kg, is planned or currently being completed as a 15-day crossover study to optimize dosing.
3
The company has not provided evidence of employing non-animal testing methods or having a formal policy regarding animal testing.
No War, No Weapons
0
The company is described as a "bioscience innovator focused on drug delivery, diagnostics, and active pharmaceutical ingredients."
1
This indicates that its core business does not involve defense or arms-related activities, nor does it develop or sell dual-use products with military applications. Consequently, there are no defense assets to divest, no need for weapons-related ethical red lines, and no exposure to controversial weapons. No other information regarding military contracts, dual-use technologies, or peacebuilding initiatives is provided in the articles.
Planet-Friendly Business
-20
The company's near-term science-based emissions reduction targets have been validated by the Science Based Targets initiative (SBTi).
1
Additionally, 72% of its suppliers, by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, are committed to science-based targets by 2027.
2
A dedicated decarbonization department was established in 2022.
3
and in 2023, measures were implemented for planning, setting yearly reduction targets, monitoring progress, and implementing decarbonization globally.
4
Dialogues were also initiated with key suppliers in 2023 to encourage them to set science-based emission reduction targets.
5
Respect for Cultures & Communities
0
BioNxt Solutions' business model, which focuses on investment in biotechnology, pharmaceuticals, and diagnostics, does not involve operations that typically necessitate Free, Prior and Informed Consent (FPIC) processes. Articles explicitly state that FPIC processes are not applicable as the company's operations do not discuss indigenous populations.
1
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided article to assess BXT.XETRA against any of the 'Safe & Smart Tech' KPIs.
1
The article is a privacy policy for BioNxt Solutions Inc.
2
and does not contain data relevant to the specified metrics.
3
Zero Waste & Sustainable Products
0
Sustainability data for BioNxt Solutions Inc. (BXT.DE) is currently unavailable
1
. The provided articles, including the company's own website
2
and a financial news source
3
, do not contain any information regarding waste management, product recyclability, packaging sustainability, or any other metrics related to zero waste and sustainable products.